105 results
424B1
AXDX
Accelerate Diagnostics Inc
22 Jan 24
Prospectus with pricing info
9:59pm
litigation costs and the results of such litigation;
the expenses we incur in connection with commercialization activities, including product marketing … information could result in regulatory or litigation-related actions against us, legal liability, fines, damages, ongoing audit requirements and other
S-1/A
AXDX
Accelerate Diagnostics Inc
16 Jan 24
IPO registration (amended)
7:18am
related costs, including litigation costs and the results of such litigation;
the expenses we incur in connection with commercialization activities … of personally identifiable information could result in regulatory or litigation-related actions against us, legal liability, fines, damages, ongoing audit
S-1
hcy4k9rb74 ll
13 Dec 23
IPO registration
5:30pm
8-K
EX-10.2
cnohehy7z n85y
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.1
0ytkg
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.3
c6abc3i7wzu
13 Jun 23
Entry into a Material Definitive Agreement
9:06am
8-K
EX-10.1
p6yopgnmq6
21 Apr 23
Entry into a Material Definitive Agreement
9:20pm
8-K
EX-10.1
i3bp1x9uwx 7y7p
13 Dec 22
Departure of Directors or Certain Officers
5:25pm
8-K
fpzsb
21 Oct 22
Other Events
4:02pm
8-K
om5f7
25 Mar 22
Entry into a Material Definitive Agreement
3:00pm
8-K
85gfsc07cv4zxaj 75p
21 Mar 22
Entry into a Material Definitive Agreement
6:06am
8-K
EX-99.2
rqxq36v4
13 Jan 22
Accelerate Diagnostics Announces Preliminary Fourth Quarter & Full-Year 2021 Financial Results
9:16am